ALPAPharmaceuticals
Alpa Laboratories Ltd — PE Ratio & Valuation Analysis
₹46.46
-9.93%
Current P/E8.59xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E16.2x47.0% below avg
✅
73.0% Discount to Industry
ALPA P/E 8.59x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹8.01 | ₹118 | 14.8x |
| 2023 | ₹5.88 | ₹103 | 17.6x |
| 2022 | ₹6.70 | ₹63 | 9.4x |
| 2021 | ₹3.45 | ₹79 | 23x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Alpa Laboratories Ltd Valuation
Alpa Laboratories Ltd (ALPA) currently trades at 8.59x earnings. The Pharmaceuticals sector average PE is 31.77x. ALPA is trading at a discount to peers — may indicate relative value. Historically, ALPA has traded at an average PE of 16.2x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
12.09%
Dividend Yield
0.00%
More on Alpa Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.